FtsEX is a bacterial ABC transporter that regulates the activity of periplasmic peptidoglycan amidases via its
Popular News Stories
Related News
Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020
October 21, 2020 6:45 am EDT Data from More Than 50 Clinical and Epidemiological Abstracts Across Vaccines, HIV, Antibiotics and Antimicrobials Show the Breadth of the...
Public Technologies 2020-10-21Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020
Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020 October 21, 2020 Key Highlights Include Data on NUZYRA as an Alternative to Standard of...
Public Technologies 2020-10-21Engineers devise new method to remove harmful E. coli from water
Engineers at Monash University have come up with an improved method to remove potentially deadly bacteria, such as E. coli, from water using graphitic carbon nitride and...
Phys Dot Org 2020-10-22Teknova completes FDA notification process for COVID-19 transport media
Contacts: Code 2003TEK Alto Marketing: VICTORIA COUPE – Senior Account Manager; E: victoriac@alto-marketing.com; T: +44(0)1489 557672 Teknova: NICOLA BROOKMAN-AMISSAH –...
Pharmiweb 2020-10-21SPOTlight supercharges cell studies
Researchers at Rice University and Baylor College of Medicine have developed a new method to isolate specific cells, and in the process found a more robust fluorescent...
Phys Dot Org 2020-10-23SurA is a cryptically grooved chaperone that expands unfolded outer membrane proteins [Biophysics and Computational Biology]
The periplasmic chaperone network ensures the biogenesis of bacterial outer membrane proteins (OMPs) and has...
PNAS 2020-10-22Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)...
Pharmiweb 2020-10-22